BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Update

BioNexus Gene Lab Corp. (NASDAQ:BGLC) was the target of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 20,100 shares, a drop of 60.0% from the February 29th total of 50,300 shares. Based on an average trading volume of 1,440,000 shares, the short-interest ratio is presently 0.0 days. Approximately 0.3% of the shares of the stock are sold short.

BioNexus Gene Lab Price Performance

BGLC opened at $0.70 on Thursday. The firm has a market cap of $12.45 million and a P/E ratio of -35.00. BioNexus Gene Lab has a 52 week low of $0.31 and a 52 week high of $17.88. The business’s fifty day simple moving average is $0.70 and its 200 day simple moving average is $0.64.

BioNexus Gene Lab Company Profile

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments.